MyMD Pharmaceuticals, Inc. (MYMD) Stock Analysis
DELISTED 2024
What happened to MyMD Pharmaceuticals, Inc. (MYMD) stock?
MyMD Pharmaceuticals, Inc. (MYMD) no longer trades on public markets. It was delisted in July 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2024
- Last recorded price (historical):
- $1.81 (last quote on record before the July 2024 delisting; historical, not a current quote)
Market cap $4.29M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
MyMD Pharmaceuticals, Inc. (MYMD). MyMD Pharmaceuticals, Inc. is a clinical development stage pharmaceutical company focused on developing therapeutic platforms to treat the causes of disease. Their lead drug candidate, MYMD-1, aims to regulate the immune system and delay aging.
Last analyzed: Mar 17, 2026MyMD Pharmaceuticals, Inc. (MYMD) Healthcare & Pipeline Overview
More about this archive record
Can I still buy MYMD shares?
No. MYMD stopped trading on public markets in July 2024, so the shares are not available through a broker. Anything you see quoted for MYMD elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MYMD stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to MyMD Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.